Found: 20
Select item for more details and to access through your institution.
High dose rhenium-186-labeling of monoclonal antibodies for clinical application.
- Published in:
- Cancer (0008543X), 1997, v. 80, n. S12, p. 2360, doi. 10.1002/(SICI)1097-0142(19971215)80:12+<2360::AID-CNCR5>3.0.CO;2-F
- By:
- Publication type:
- Article
Facile labelling of an anti-epidermal growth factor receptor Nanobody with Ga via a novel bifunctional desferal chelate for immuno-PET.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2011, v. 38, n. 4, p. 753, doi. 10.1007/s00259-010-1700-1
- By:
- Publication type:
- Article
p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 2, p. 250, doi. 10.1007/s00259-009-1263-1
- By:
- Publication type:
- Article
<sup>124</sup>I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of <sup>131</sup>I-L19-SIP radioimmunotherapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2009, v. 36, n. 8, p. 1235, doi. 10.1007/s00259-009-1096-y
- By:
- Publication type:
- Article
Quantitative PET imaging of Met-expressing human cancer xenografts with <sup>89</sup>Zr-labelled monoclonal antibody DN30.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2008, v. 35, n. 10, p. 1857, doi. 10.1007/s00259-008-0774-5
- By:
- Publication type:
- Article
Preparation and evaluation of <sup>89</sup>Zr-Zevalin for monitoring of <sup>90</sup>Y-Zevalin biodistribution with positron emission tomography.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2006, v. 33, n. 11, p. 1337, doi. 10.1007/s00259-006-0160-0
- By:
- Publication type:
- Article
High-quality<sup>124</sup>I-labelled monoclonal antibodies for use as PET scouting agents prior to<sup>131</sup>I-radioimmunotherapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2004, v. 31, n. 12, p. 1645, doi. 10.1007/s00259-004-1632-8
- By:
- Publication type:
- Article
<sup>89</sup>Zr-Nanocolloidal Albumin--Based PET/CT Lymphoscintigraphy for Sentinel Node Detection in Head and Neck Cancer: Preclinical Results.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 10, p. 1580, doi. 10.2967/jnumed.111.089557
- By:
- Publication type:
- Article
Immuno-PET: A Navigator in Monoclonal Antibody Development and Applications.
- Published in:
- Oncologist, 2007, v. 12, n. 12, p. 1379, doi. 10.1634/theoncologist.12-12-1379
- By:
- Publication type:
- Article
The preparation of aromatic astatine compounds through aromatic mercury compounds part II: Astatination of pyrimidines and steroids.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 1981, v. 18, n. 6, p. 799, doi. 10.1002/jlcr.2580180606
- By:
- Publication type:
- Article
The preparation of aromatic astatine compounds through aromatic mercury-compounds.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 1980, v. 17, n. 5, p. 657, doi. 10.1002/jlcr.2580170508
- By:
- Publication type:
- Article
<sup>89</sup>Zr as a PET Surrogate Radioisotope for Scouting Biodistribution of the Therapeutic Radiometals <sup>90</sup>Y and <sup>177</sup>Lu in Tumor-Bearing Nude Mice After Coupling to the Internalizing Antibody Cetuximab.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 11, p. 1898
- By:
- Publication type:
- Article
The Promise of Immuno-PET in Radioimmunotherapy.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 2, p. 164S
- By:
- Publication type:
- Article
Quantitative <sup>89</sup>Zr Immuno-PET for In Vivo Scouting of <sup>90</sup>Y-Labeled Monoclonal Antibodies in Xenograft-Bearing Nude Mice.
- Published in:
- Journal of Nuclear Medicine, 2003, v. 44, n. 10, p. 1663
- By:
- Publication type:
- Article
<sup>89</sup>Zr Immuno-PET: Comprehensive Procedures for the Production of <sup>89</sup>Zr-Labeled Monoclonal Antibodies.
- Published in:
- Journal of Nuclear Medicine, 2003, v. 44, n. 8, p. 1271
- By:
- Publication type:
- Article
Optimal Quality <sup>131</sup>I-Monoclonal Antibodies on High-Dose Labeling in a Large Reaction Volume and Temporarily Coating the Antibody with IODO-GEN.
- Published in:
- Journal of Nuclear Medicine, 2001, v. 42, n. 3, p. 509
- By:
- Publication type:
- Article
Radioimmunotherapy with Intravenously Administered <sup>131</sup>I-Labeled Chimeric Monoclonal Antibody MOv18 in Patients with Ovarian Cancer.
- Published in:
- Journal of Nuclear Medicine, 2000, v. 41, n. 7, p. 1168
- By:
- Publication type:
- Article
Monoclonal Antibodies Labeled with Rhenium-186 Using the MAG3 Chelate: Relationship between the Number of Chelated Groups and Biodistribution Characteristics.
- Published in:
- Journal of Nuclear Medicine, 1996, v. 37, n. 2, p. 352
- By:
- Publication type:
- Article
Labeling of Monoclonal Antibodies with Rhenium-186 Using the MAG3 Chelate for Radioimmunotherapy of Cancer: A Technical Protocol.
- Published in:
- Journal of Nuclear Medicine, 1993, v. 34, n. 11, p. 1953
- By:
- Publication type:
- Article
Early Treatment Response in Malignant Lymphoma, As Determined by Planar Fluorine-18-Fluorodeoxyglucose Scintigraphy.
- Published in:
- Journal of Nuclear Medicine, 1993, v. 34, n. 10, p. 1706
- By:
- Publication type:
- Article